Avinger Inc financial data

Symbol
AVGR on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
400 Chesapeake Drive, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 91 % +5.04%
Quick Ratio 30.7 % +13.9%
Debt-to-equity 4.38K %
Return On Equity -5.43K % -511%
Return On Assets -121 % -37.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.2M shares +133%
Common Stock, Shares, Outstanding 2.78M shares +118%
Entity Public Float 6.8M USD -22.7%
Common Stock, Value, Issued 3K USD +200%
Weighted Average Number of Shares Outstanding, Basic 2.22M shares +219%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 5.74M USD +5.63%
Research and Development Expense 4.2M USD -7.28%
Operating Income (Loss) -17.5M USD -10.5%
Net Income (Loss) Attributable to Parent -18.6M USD -6.47%
Earnings Per Share, Basic -7.96 USD/shares +89.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.9M USD -18%
Accounts Receivable, after Allowance for Credit Loss, Current 877K USD +5.92%
Inventory, Net 3.76M USD -32.6%
Assets, Current 11.5M USD -26.8%
Property, Plant and Equipment, Net 466K USD -11.7%
Operating Lease, Right-of-Use Asset 1.43M USD +3.11%
Other Assets, Noncurrent 224K USD -10%
Assets 13.6M USD -23.8%
Accounts Payable, Current 921K USD +67.8%
Employee-related Liabilities, Current 1.96M USD +0.77%
Accrued Liabilities, Current 589K USD -34.3%
Liabilities, Current 9.5M USD -48.3%
Operating Lease, Liability, Noncurrent 217K USD +5.85%
Other Liabilities, Noncurrent 6K USD -99%
Liabilities 9.73M USD -49.3%
Retained Earnings (Accumulated Deficit) -434M USD -1.9%
Stockholders' Equity Attributable to Parent 3.88M USD
Liabilities and Equity 13.6M USD -23.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.73M USD -12.4%
Net Cash Provided by (Used in) Financing Activities 6.63M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.78M shares +118%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.9M USD
Deferred Tax Assets, Valuation Allowance 99.4M USD +3.51%
Deferred Tax Assets, Gross 99.6M USD +3.19%
Operating Lease, Liability 1.43M USD +3.11%
Payments to Acquire Property, Plant, and Equipment 0 USD
Lessee, Operating Lease, Liability, to be Paid 1.48M USD +2.64%
Property, Plant and Equipment, Gross 4.59M USD -1.37%
Operating Lease, Liability, Current 1.21M USD +2.63%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.17M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 313K USD -72.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 52K USD -8.77%
Deferred Tax Assets, Operating Loss Carryforwards 87.6M USD +2.36%
Preferred Stock, Shares Issued 30.2K shares -51.9%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.68M USD +3.8%
Preferred Stock, Shares Outstanding 30.2K shares -51.9%
Depreciation, Depletion and Amortization 83K USD +15.3%
Deferred Tax Assets, Net of Valuation Allowance 278K USD -50.4%
Share-based Payment Arrangement, Expense 1.76M USD +151%
Interest Expense 1.13M USD -32.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%